17β-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1 adipocytes

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 979-985

  Kim, Ju Young ^a   Jo, Kyung Jin ^b   Kim, Byung Joon ^c   Baik, Haing Woon ^d   Lee, Seong Kyu ^d  

^a Soonchunhyang University   (South Korea)

^b Korea Institute of Toxicology   (South Korea)

^c Konyang University   (South Korea)

^d Eulji University   (South Korea)

Author keywords

17 estradiol; Adenosine monophosphate activated protein kinase; Estrogen receptor; Glucose metabolism; Insulin signaling

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; ESTRADIOL; FULVESTRANT; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR ALPHA; PROTEIN KINASE B; TYROSINE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE METABOLISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENZYME ACTIVATION; ESTRADIOL; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84866501867     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1070     Document Type: Article

References (37)

1. Liu S and Mauvais-Jarvis F: Minireview: estrogenic protection of β-cell failure in metabolic diseases. Endocrinology 151: 859-864, 2010.
2. Schneider JG, Tompkins C, Blumenthal RS and Mora S: The metabolic syndrome in women. Cardiol Rev 14: 286-291, 2006.
3. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR and Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436, 2003.
4. Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kröger H, Alhava E and Saarikoski S: Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study. Eur J Endocrinol 160: 979-983, 2009.
5. Richards L: Diabetes: Postmenopausal hormone therapy prevents diabetes. Nat Rev Endocrinol 5: 352, 2009.
6. Liang YQ, Akishita M, Kim S, Ako J, Hashimoto M, Iijima K, Ohike Y, Watanabe T, Sudoh N, Toba K, et al: Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 26: 1103-1109, 2002.
7. Liu ML, Xu X, Rang WQ, Li YJ and Song HP: Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int J Cardiol 97: 485-493, 2004.
8. Paquette A, Shinoda M, Rabasa Lhoret R, Prud'homme D and Lavoie JM: Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 58: 182-190, 2007.
9. Saengsirisuwan V, Pongseeda S, Prasannarong M, Vichaiwong K and Toskulkao C: Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 58: 38-47, 2009.
10. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R and Gourdy P: Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 150: 2109-2117, 2009.
11. Hewitt SC, Harrell JC and Korach KS: Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67: 285-308, 2005.
12. Levin ER: Rapid signaling by steroid receptors. Am J Physiol Regul Integr Comp Physiol 295: R1425-R1430, 2008.
13. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA and Hathaway HJ: Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70: 165-190, 2008.
14. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB and Cooke PS: Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA 97: 12729-12734, 2000.
15. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly-Y M, Rudling M, Lindberg MK, Warner M, Angelin B and Gustafsson JA: Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 278: 640-645, 2000.
16. Lage R, Diéguez C, Vidal-Puig A and López M: AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14: 539-549, 2008.
17. Saltiel AR and Kahn CR: Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
18. Horike N, Takemori H, Katoh Y, Doi J, Min L, Asano T, Sun XJ, Yamamoto H, Kasayama S, Muraoka M, et al: Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem 287: 18440-18447, 2003.
19. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK and Greenberg AS: Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280: 35983-35991, 2005.
20. Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ and Greenberg AS: Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 382: 646-650, 2009.
21. D'Eon TM, Rogers NH, Stancheva ZS and Greenberg AS: Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes. Obesity (Silver Spring) 16: 1284-1288, 2008.
22. Lee YR, Park J, Yu HN, Kim JS, Youn HJ and Jung SH: Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Commun 336: 1221-1226, 2005.
23. Gorres BK, Bomhoff GL, Morris JK and Geiger PC: In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake. J Physiol 589: 2041-2054, 2011.
24. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T and Walsh K: Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309, 2004.
25. Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG IV, Schlattner U, Neumann D, Brownlee M, Freeman MB and Goldman MH: Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279: 43940-43951, 2004.
26. Muraki K, Okuya S and Tanizawa Y: Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J 53: 841-851, 2006.
27. Naaz A, Zakroczymski M, Heine P, Taylor J, Saunders P, Lubahn D and Cooke PS: Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ER alpha): a potential role for estrogen receptor beta (ER beta). Horm Metab Res 34: 758-763, 2002.
28. Sharma G and Prossnitz ER: Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 152: 3030-3039, 2011.
29. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J and Thomas P: Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245, 2007.
30. Puigserver P and Spiegelman BM: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90, 2003.
31. Knutti D and Kralli A: PGC-1, a versatile coactivator. Trends Endocrinol Metab 12: 360-365, 2001.
32. Diano S and Horvath TL: Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism. Trends Mol Med 18: 52-58, 2012.
33. Saleh MC, Wheeler MB and Chan CB: Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45: 174-187, 2002.
34. Pecqueur C, Couplan E, Bouillaud F and Ricquier D: Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J Mol Med (Berl) 79: 48-56, 2001.
35. Ryder JW, Gilbert M and Zierath JR: Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front Biosci 6: D154-D163, 2001.
36. Bell GI and Polonsky KS: Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414: 788-791, 2001.
37. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946, 2001.